References
- Breslin TM, Banerjee M, Gust C, Birkmeyer NJ. Trends in advanced imaging use for women undergoing breast cancer surgery. Cancer 2013; 119: 1251-6. 10.1002/cncr.2783823212691
- Houssami N, Hayes DF. Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer? CA Cancer J Clin 2009; 59: 290-302. 10.3322/caac.2002819679690
- Teifke A, Lehr HA, Vomweg TW, Hlawatsch A, Thelen M. Outcome analysis and rational management of enhancing lesions incidentally detected on contrast-enhanced MRI of the breast. AJR Am J Roentgenol 2003; 181: 655-62. 10.2214/ajr.181.3.181065512933456
- Brennan ME, Houssami N, Lord S, Macaskill P, Irwig L, Dixon JM, et al. Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and metaanalysis of incremental cancer detection and impact on surgical management J Clin Oncol 2009; 27: 5640-9. 10.1200/JCO.2008.21.5756
- Houssami N, Turner R, Morrow M. Preoperative magnetic resonance imaging in breast cancer: meta-analysis of surgical outcomes. Ann Surg 2013; 257: 249-55. 10.1097/SLA.0b013e31827a8d1723187751
- Arponen O, Masarwah A, Sutela A, Taina M, Könönen M, Sironen R, et al. Incidentally detected enhancing lesions found in breast MRI: analysis of apparent diffusion coefficient and T2 signal intensity significantly improves specificity. Eur Radiol 2016; 26: 4361-70. 10.1007/s0033-016-4326-227114285
- Spick C, Baltzer PA. Diagnostic utility of second-look US for breast lesions identified at MR imaging: systematic review and meta-analysis. Radiology 2014; 273: 401-9. 10.1148/radiol.1414047425119022
- Hollowell L, Price E, Arasu V, Wisner D, Hylton N, Joe B. Lesion morphology on breast MRI affects targeted ultrasound correlation rate. Eur Radiol 2015; 25: 1279-84. 10.1007/s00330-014-3517-y25500714
- Newburg AR, Chhor CM, Young Lin LL, Heller SL, Gillman J, Toth HK, et al. Magnetic resonance imaging-directed ultrasound imaging of non-mass enhancement in the breast: Outcomes and frequency of malignancy. J Ultrasound Med 2017; 36: 493-504. 10.7863/ultra.16.0300128108994
- Gao Y, Bagadiya NR, Jardon ML, Heller SL, Melsaether AN, Toth HB, et al. Outcomes of preoperative MRI-guided needle localization of nonpalpable mammographically occult breast lesions. AJR Am J Roentgenol 2016; 207: 676-84. 10.2214/AJR.15.1591327275652
- Wilson SR, Greenbaum LD, Goldberg BB. Contrast-enhanced ultrasound: what is the evidence and what are the obstacles? AJR Am J Roentgenol 2009; 193: 55-60. 10.2214/AJR.09.255319542395
- Buckley DL, Drew PJ, Mussurakis S, Monson JR, Horsman A. Microvessel density of invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI. J Magn Reson Imaging 1997; 7: 461-4.10.1002/jmri.18800703029170027
- Giesel FL, Choyke PL, Mehndiratta A, Zechmann CM, von Tengg-Kobligk H, Kayser K. Pharmacokinetic analysis of malignant pleural mesothelioma-initial results of tumor microcirculation and its correlation to microvessel density (CD-34). Acad Radiol 2008; 15: 563-70. 10.1016/j.acra.2007.12.01418423312
- Knopp MV, Weiss E, Sinn HP, Mattern J, Junkermann H, Radeleff J, et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 1999; 10: 260-6.10.1002/(SICI)1522-2586(199909)10:3<;260::AID-JMRI6>3.0.CO;2-710508285
- Hayes C, Padhani AR, Leach MO. Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed 2002; 15: 154-63.1187091110.1002/nbm.756
- Jansen SA, Paunesku T, Fan X, Woloschak GE, Vogt S, Conzen SD, et al. Ductal carcinoma in situ: X-ray fluorescence microscopy and dynamic contrast-enhanced MR imaging reveals gadolinium uptake within neoplastic mammary ducts in a murine model. Radiology 2009; 253: 399-406. 10.1148/radiol.2533082026
- Giorgio R, Roberta C. Enhancing the role of ultrasound with contrast agents. Milan: Springer; 2006.
- Du J, Wang L, Wam CF, Hua J, Fang H, Chen J, et al. Differentiating benign from malignant solid breast lesions: combined utility of conventional ultrasound and contrast-enhanced ultrasound in comparison with magnetic resonance imaging. Eur J Radiol 2012; 81: 3890-9. 10.1016/j.ejrad.2012.09.00423062280
- Jiang YX, Liu H, Liu JB, Zhu QL, Sun Q, Chang XY. Breast tumor size assessment: comparison of conventional ultrasound and contrast-enhanced ultrasound. Ultrasound Med Biol 2007; 33: 1873-81. 10.1016/j.ultrasmedbio.2007.06.00217686569
- Corcioni B, Santilli L, Quercia S, Zamagni C, Santini D, Taffurelli M, et al. Contrast-enhanced US and MRI for assessing the response of breast cancer to neoadjuvant chemotherapy. J Ultrasound 2008; 11: 143-50. 10.1016/j.jus.2008.09.00723396645
- Fujisawa T, Hirakata T, Yanagita Y, Iijima M, Horikoshi H, Takeuchi K, et al. The detection of pCR after PST by contrast-enhanced ultrasonography for breast cancer. Breast Cancer 2013; 20: 75-82. 10.1007/s12282-011-0311-422203579
- Rautiainen S, Sudah M, Joukainen S, Sironen R, Vanninen R, Sutela A. Contrast-enhanced ultrasound -guided axillary lymph node core biopsy: Diagnostic accuracy in preoperative staging of invasive breast cancer. Eur J Radiol 2015; 84: 2130-6. 10.1016/j.ejrad.2015.08.00626343047
- Sardanelli F, Boetes C, Borisch B, Decker T, Federico M, Gilbert FJ, et al. Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer 2010; 46: 1296-316. 10.1016/j.ejca.2010.02.015
- Abe H, Schmidt RA, Shah RN, Shimauchi A, Kulkarni K, Sennett CA, et al. MR-directed (“Second-Look”) ultrasound examination for breast lesions detected initially on MRI: MR and sonographic findings. AJR Am J Roentgenol 2010; 194: 370-7. 10.2214/AJR.09.270720093598
- Westwood M, Joore M, Grutters J, Redekop K, Armstrong N, Lee K, et al. Contrast-enhanced ultrasound using SonoVue(R) (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis. Health TechnolAssess 2013; 17: 1-243. 10.3310/hta17160
- Heijblom M, Klaase JM, van den Engh FM, van Leeuwen TG, Steenberg W, Manohar S. Imaging tumor vascularization for detection and diagnosis of breast cancer. Technol Cancer Res Treat 2011; 10: 607-23. 10.7785/tcrt.2012.50022722066601
- Santamaria G, Velasco M, Farrús B, Caparrós FX, Fernández PL. Dynamic contrast-enhanced MRI reveals the extent and the microvascular pattern of breast ductal carcinoma in situ. Breast J 2013; 19: 402-10. 10.1111/tbj.1213523758454
- Chevrier MC, David J, Khoury ME, Lalonde L, Labelle M, Trop I. Breast biopsies under magnetic resonance imaging guidance: Challenges of an essential but imperfect technique. Curr Probl Diagn Radiol 2016; 45: 193-204. 10.1067/j.cpradiol.2015.07.00226272705
- Choi HY, Kim SM, Jang M, Yun BL, Kim SW, Kang E, et al. MRI-guided intervention for breast lesions using the freehand technique in a 3.0-T closedbore MRI scanner: feasibility and initial results. Korean J Radiol 2013; 14: 171-8. 10.3348/kjr.2013.14.2.171